SHR-7787 injection

DRUG2 trials

Sponsors

Shanghai Hengrui Pharmaceutical Co., Ltd.

Conditions

Advanced Solid TumorsMalignant Solid Tumors

Phase 1

A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors

RecruitingNCT06605222

Shanghai Hengrui Pharmaceutical Co., Ltd.Advanced Solid Tumors

Start: 2024-10-04End: 2026-11-30Target: 201Updated: 2024-10-18

Phase 2

A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors

RecruitingNCT07268040

Shanghai Hengrui Pharmaceutical Co., Ltd.Malignant Solid Tumors

Start: 2025-12-23End: 2028-12-31Target: 400Updated: 2026-01-12